Analysis of the incidence and safety of major adverse cardiovascular events in ticagrelor for percutaneous coronary intervention in patients with high SYNTAX score

Tao Ying; Zhang Jingmei; Gao Yulong; Lin Yun; Wang Su; Li Zhizhong

doi:10.3760/j.issn.1673-4777.2020.08.008

Home>Articles>Analysis of the incidence and safety of major adverse cardiovascular events in ticagrelor for percutaneous coronary intervention in patients with high SYNTAX score

DOI: 10.3760/j.issn.1673-4777.2020.08.008

Analysis of the incidence and safety of major adverse cardiovascular events in ticagrelor for percutaneous coronary intervention in patients with high SYNTAX score

Tao Ying

Zhang Jingmei

Gao Yulong

Lin Yun

Wang Su

Li Zhizhong

Machine-generated Keywords：

Publication Date：2020-08-08

Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)

Pages：5( 1183-1187 )

China Medicine

ISTIC

ISSN：1673-4777

Year, Vol.(Issue)：2020,15(8)